| Terlipressin acetate EVER Pharma 0.2 mg/ml solution for injection PA1774/007/001 |
Terlipressin acetate |
EVER Valinject GmbH |
Marketed |
| Terrosa 20 micrograms/80 microliters solution for injection EU/1/16/1159/001-002 |
Teriparatide |
Gedeon Richter Plc |
— |
| Tesavel 100 mg film-coated tablets EU/1/07/435/13-18 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV |
— |
| Tesavel 25 mg film-coated tablets EU/1/07/435/1-6 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV, |
— |
| Tesavel 50 mg film-coated tablets EU/1/07/435/7-12 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV |
— |
| Testarzon 20 mg/g Transdermal gel PA23202/001/001 |
Testosterone |
The Simple Pharma Company Limited |
Marketed |
| Testogel 16.2 mg/g, Gel PA1054/002/004 |
Testosterone |
Laboratoires Besins International |
Marketed |
| Testogel 40.5 mg transdermal gel in sachet PA1054/002/005 |
Testosterone |
Laboratoires Besins International |
Marketed |
| Testogel 50 mg transdermal gel in sachet PA1054/002/002 |
Testosterone |
Laboratoires Besins International |
Marketed |
| Testogel 50 mg transdermal gel in sachet PPA23080/032/001 |
Testosterone |
Merit Pharmaceuticals Limited |
— |
| Testosterone Besins 1000 mg/4 ml solution for injection PA22624/002/001 |
Testosterone Undecanoate |
Besins Healthcare Ireland Limited |
Not marketed |
| Testosterone undecanoate EVER Pharma 1000 mg/4 ml solution for injection PA1774/010/001 |
Testosterone Undecanoate |
EVER Valinject GmbH |
Not marketed |
| Tetagam P, prefilled syringeSolution for injection for intramuscular use PA0800/009/002 |
Human plasma protein |
CSL Behring GmbH |
Marketed |
| Tetrabenazine 25 mg Tablets PA25429/003/001 |
Tetrabenazine |
Walter Ritter GmbH & Co. KG |
Marketed |
| Tetralysal 300 mg hard capsules PPA0465/256/001 |
Lymecycline |
PCO Manufacturing Ltd. |
— |
| Tetralysal 300 mg hard capsules PPA1463/133/001 |
Tetracycline |
IMED Healthcare Ltd., |
— |
| Tetralysal 300mg Hard Capsules PA22743/016/001 |
Lymecycline |
Galderma International |
Marketed |
| Tetravac, suspension for injection in prefilled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, (adsorbed). PA23458/007/001 |
Adsorbed purified pertussis toxoid, Adsorbed purified filamentous haemagglutinin, Purified tetanus toxoid, Purified diphtheria toxoid ph. eur., Inactivated type 1 poliovirus |
Sanofi Winthrop Industrie |
Marketed |
| Tetridar 20 micrograms/80 microlitres Solution for Injection in pre-filled pen PA1986/053/001 |
Teriparatide |
Teva B.V. |
Marketed |
| Tevagrastim 30 MIU/0.5 mL solution for injection/infusion EU/1/08/445/1-4 |
Filgrastim |
Teva Generics GmbH |
— |
| Tevagrastim 48 MIU/0.8 mL solution for injection/infusion EU/1/08/445/5-8 |
Filgrastim |
Teva Generics GmbH |
— |
| Tevanate Once Weekly 70mg Tablets PA0749/016/001 |
Alendronate sodium monohydrate |
Teva Pharma B.V. |
Marketed |
| Tevaquel 100 mg Film-coated Tablets PA0749/060/002 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel 200 mg Film-coated Tablets PA0749/060/004 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel 25 mg Film-coated Tablets PA0749/060/001 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel 300 mg Film-coated Tablets PA0749/060/005 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel XL 200 mg Prolonged-release tablets PA0749/060/007 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel XL 300 mg Prolonged-release tablets PA0749/060/008 |
Quetiapine fumarate |
Teva Pharma B.V. |
Marketed |
| Tevaquel XL 400 mg Prolonged-release tablets PA0749/060/009 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| Tevaquel XL 50 mg prolonged-release tablets PA0749/060/006 |
Quetiapine |
Teva Pharma B.V. |
Marketed |
| TEVETEN 400 mg, film-coated tablets PA23355/020/001 |
Eprosartan |
Viatris Healthcare Limited |
Marketed |
| Teveten 600 mg film-coated tablets PPA0465/469/001 |
Eprosartan |
PCO Manufacturing Ltd. |
— |
| Teveten 600 mg, film-coated tablets PA23355/020/002 |
Eprosartan |
Viatris Healthcare Limited |
Marketed |
| Teveten Plus 600 mg/12.5 mg film-coated tablets PA23355/021/001 |
Eprosartan, Hydrochlorothiazide |
Viatris Healthcare Limited |
Marketed |
| Teveten Plus 600 mg/12.5 mg film-coated tablets PPA0465/448/001 |
Hydrochlorothiazide, Eprosartan |
PCO Manufacturing Ltd. |
— |
| Tevimbra 100 mg concentrate for solution for infusion EU/1/23/1758/001-002 |
Tislelizumab |
BeiGene Ireland Limited |
— |
| Teysuno 15 mg/4.35 mg/11.8 mg hard capsules EU/1/11/669/001-002 |
Tegafur, Gimeracil, Oteracil (as monopotassium salt) |
Nordic Group B.V. |
— |
| Teysuno 20 mg/5.8 mg/15.8 mg hard capsules EU/1/11/669/003-004 |
Gimeracil, Oteracil (as monopotassium salt), Tegafur |
Nordic Group B.V. |
— |
| Tezspire 210 mg solution for injection in pre-filled syringe EU/1/22/1677/001-002 |
Tezepelumab |
AstraZeneca AB |
— |
| Thalidomide BMS 50 mg hard capsules EU/1/08/443/1 |
Thalidomide |
Bristol-Myers Squibb Pharmaceuticals uc |
— |
| Thalidomide Lipomed 100 mg coated tablets EU/1/22/1676/001 |
Thalidomide |
Lipomed GmbH |
— |
| Thallous (Tl201) chloride injection 37 MBq/ml solution for injection PA0690/016/001 |
Thallous chloride (201 tl) |
Curium Netherlands B.V. |
Marketed |
| Thamicarb 84 mg/ml Oral Solution PA22697/017/001 |
Sodium hydrogen carbonate |
Syri Pharma Limited t/a Thame Laboratories |
Marketed |
| Theralugand EU/1/24/1852/001-002 |
Lutetium (177lu) chloride |
Eckert & Ziegler Radiopharma GmbH |
— |
| Thiotepa Fresenius Kabi 100 mg powder for concentrate for solution for infusion PA2059/079/002 |
Thiotepa |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Thiotepa Fresenius Kabi 15 mg powder for concentrate for solution for infusion PA2059/079/001 |
Thiotepa |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Thiotepa Riemser 100 mg powder for concentrate for solution for infusion EU/1/21/1536/002 |
Thiotepa |
Esteve Pharmaceuticals GmbH |
— |
| Thiotepa Riemser 15 mg powder for concentrate for solution for infusion EU/1/21/1536/001 |
Thiotepa |
Esteve Pharmaceuticals GmbH |
— |
| THORENS 10 000 I.U. /ml oral drops, solution PA22680/005/001 |
Cholecalciferol |
Galen Pharma Ireland Limited |
Marketed |
| THORENS 25 000 I.U. /2.5 ml oral solution PA22680/005/002 |
Cholecalciferol |
Galen Pharma Ireland Limited |
Marketed |